Heyman Richard A.

SEC Form 4 insider trading activity

Heyman Richard A. has filed 8 SEC Form 4 filings (17 transaction rows) across 2 companies, including ORIC, ELVN, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.

On the most recent filing, Heyman Richard A. is listed as Director at Oric Pharmaceuticals, Inc. Inside the rolling window, Heyman Richard A. reported no open-market purchases and 8 open-market sales totaling $741K in ORIC and ELVN. The largest disclosed transaction in the window is a sale of 9,635 ELVN shares on Jan 8, 2026, worth $241K.

Companies traded

Other insiders at ORIC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$741K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ORICSale$87KOct 2SEC ↗
ORICSale$157KJul 28SEC ↗
ORICSale$4KJul 8SEC ↗
ELVNSale$32KFeb 19SEC ↗
ELVNSale$33KJan 22SEC ↗
ORICSale$80KJan 20SEC ↗
ELVNSale$241KJan 12SEC ↗
ELVNSale$107KJan 12SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Heyman Richard A. made?

Heyman Richard A. has filed 8 SEC Form 4 filings (17 transaction rows) across 2 companies, including ORIC, ELVN since 2025.

Which companies does Heyman Richard A. trade?

Heyman Richard A. has filed SEC Form 4 disclosures for 2 companies, including ORIC, ELVN.

When was Heyman Richard A.'s most recent SEC Form 4 filing?

Heyman Richard A.'s most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.

What is Heyman Richard A.'s total buy and sell value in the current window?

Inside the rolling retention window, Heyman Richard A. bought $0 and sold $741K based on SEC Form 4 filings.

What was Heyman Richard A.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 9,635 ELVN shares on 2026-01-08, worth $241K, per SEC Form 4 filings.